Cargando…
Repeated BCG treatment of mouse bladder selectively stimulates small GTPases and HLA antigens and inhibits single-spanning uroplakins
BACKGROUND: Despite being a mainstay for treating superficial bladder carcinoma and a promising agent for interstitial cystitis, the precise mechanism of Bacillus Calmette-Guerin (BCG) remains poorly understood. It is particularly unclear whether BCG is capable of altering gene expression beyond its...
Autores principales: | Saban, Marcia R, Hellmich, Helen L, Simpson, Cindy, Davis, Carole A, Lang, Mark L, Ihnat, Michael A, O'Donnell, Michael A, Wu, Xue-Ru, Saban, Ricardo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212656/ https://www.ncbi.nlm.nih.gov/pubmed/17980030 http://dx.doi.org/10.1186/1471-2407-7-204 |
Ejemplares similares
-
Molecular networks discriminating mouse bladder responses to intravesical bacillus Calmette-Guerin (BCG), LPS, and TNF-α
por: Saban, Marcia R, et al.
Publicado: (2008) -
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
por: Saban, Marcia R, et al.
Publicado: (2007) -
Transcription factor network downstream of protease activated receptors (PARs) modulating mouse bladder inflammation
por: Saban, Ricardo, et al.
Publicado: (2007) -
Mandatory role of proteinase-activated receptor 1 in experimental bladder inflammation
por: Saban, Ricardo, et al.
Publicado: (2007) -
VEGF signaling mediates bladder neuroplasticity and inflammation in response to BCG
por: Saban, Marcia R, et al.
Publicado: (2011)